The Food and Drug Administration (FDA) gave a life ban to Talib Khan, the co-founder of a fake medical company called Gallant Pharma International Inc., headquartered in Arlington, Virginia. The agency filed the ruling under the Federal Food, Drug, and Cosmetic Act preventing Khan from providing any form of service to a person or company working on an approved or pending drug product application.

A violation of this order would result in “civil money penalties,” according to the FDA’s ruling. 

Khan co-founded and co-owned Gallant Pharma International Inc., worth about $12 million, between 2009 and 2013.  For four years, the company operated as an unlicensed wholesaler of prescription drugs.

Khan’s firm worked with international drug suppliers to have “chemotherapy drugs and injectable cosmetic drugs and devices” shipped to the United Kingdom and Canada and later, sent to the United States, writes InPharma Technologist.

The catch, though, was that these products did not have FDA approval for use in the U.S. Furthermore, Khan had hired sales reps to sell these drugs in the U.S., which were misbranded and had incorrect labeling and packaging instructions. 

Khan admitted his company had made  at least $12.4 million in sales revenue after he plead guilty to a charge of criminal conspiracy and importation fraud in 2013. 

The FDA sent a notice of the permanent debarment to Khan on March 23, 2015. He failed to respond to the ruling in an appropriate timeframe, therefore preventing him from being able to request a hearing.